Immunotherapy for Head and Neck Cancer Treatment
1 ビュー
• 07/02/23
0
0
埋め込む
administrator
加入者
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント